The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
NCT07718204 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-07-21
Summary
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:
* Is the MedMemos intervention acceptable to patients and families?
* Is the MedMemos intervention feasible for patients, families, and healthcare providers?
* Does MedMemos help patients and families take their medications better?
Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
Conditions
- Hematopoietic Cell Transplant
Interventions
- BEHAVIORAL
-
MedMemos
MedMemos is a 4-session tailored adherence promotion intervention that will provide caregivers with a combination of tailored and standardized medication and adherence education videos and a "Medication Management Kit" that provides tailored strategies to target identified barriers to successful medication management.
Sponsors & Collaborators
-
Nationwide Children's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 0 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
NCT02120157 ·Status: COMPLETED ·Phase: PHASE2
-
Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
NCT00002534 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
NCT00003187 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
NCT04904588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
NCT02793544 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
NCT00013533 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
NCT00412360 ·Status: COMPLETED ·Phase: PHASE3
-
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
NCT06926595 ·Status: RECRUITING ·Phase: PHASE2
-
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
NCT05457556 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
NCT03214354 ·Status: RECRUITING ·Phase: PHASE2
-
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
NCT06859424 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
NCT00002553 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell Transplant Survivors
NCT07375290 ·Status: RECRUITING ·Phase: PHASE1
-
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetic Study of Melphalan in Pediatric Hematopoietic Stem Cell Transplantation
NCT04937634 ·Status: UNKNOWN ·Phase: PHASE1
-
iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant
NCT02378012 ·Status: TERMINATED ·Phase: NA
-
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
NCT06839456 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia
NCT00001144 ·Status: COMPLETED ·Phase: PHASE2
-
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
NCT00566696 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies
NCT02623439 ·Status: TERMINATED ·Phase: PHASE2
-
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL
NCT01423500 ·Status: UNKNOWN ·Phase: PHASE3
-
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
NCT03970096 ·Status: RECRUITING ·Phase: PHASE2
-
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00005641 ·Status: TERMINATED ·Phase: PHASE2
-
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
NCT00429143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
NCT03128996 ·Status: RECRUITING ·Phase: PHASE1/PHASE2